Saving Lives with Cellular Therapy
Monday, October 16
with Dr. Uri Greenbaum and Prof. Rivka Carmi
1345 Avenue of the America, New York
Dr. Uri Greenbaum
Head of the cellular therapy for cancer service, Soroka University Medical Center
Dr. Uri Greenbaum attended medical school in Beer Sheva and went on to a residency in internal medicine and a sub-specialty in hematology at Soroka University Medical Center.
After completing board certification in Israel, Dr. Greenbaum was the first fellow in a new program at the University of Texas MD Anderson Cancer Center in Houston, Texas. The two-year fellowship was a clinical and research program in cellular therapy for cancer, a novel therapeutic approach for treating malignancies using the immune system.
In August 2021 Dr. Greenbaum returned to Soroka Medical Center and initiated a cellular therapy program, focusing on CAR T therapy for lymphoma and leukemia. He has since treated patients in the underserved Negev region with this novel therapy and is now planning to expand the service to experimental therapies and local production of the treatment, enabling state-of-the-art care for his patients.
He is also a lecturer at Ben-Gurion University and has published scientific papers in journals in the field of hemo-oncology. He now consults for companies on cellular therapy.
Prof. Rivka Carmi
Prof. Rivka Carmi served as President of Ben-Gurion University of the Negev between the years 2006-2018 and prior to that as the dean of the Faculty of Health Sciences at BGU. A graduate of Hadassah Medical School of the Hebrew University she is a board-certified Pediatrician, Neonatologist, and Medical Geneticist who also served as the Director of the Genetics Institute at the Soroka University Medical Center. In 2010, she became the first woman to chair Israel’s Committee of University Heads.
Prof. Carmi’s research, with over 150 publications, focused on the delineation of the clinical manifestations and molecular basis of genetic diseases in the Negev Arab-Bedouin population, where she has identified 12 new genes and delineated 2 new syndromes, one of which bears her name (OMIM #226730).
Prof. Carmi has been awarded many prizes, among them, Honorary Doctorate degrees from Dalhousie and Brandeis Universities. In 2015, she was declared an honorary Commander of the British Empire (CBE) in the name of Queen Elizabeth II. In 2020 she received the Landau Lifetime Award in Medicine.
Currently, Prof. Carmi serves as the Founding President of the Israel National Academy of Science in Medicine by the Israeli Medical Association; Chairwoman of ScienceAbroad executive committee; Chairwoman of TELEM ( the Forum for National Research Infrastructures) Scientific Advisory Council for Bio-convergence; Chairwoman of the advisory Committee for Medical Education of the Council of Higher Education; board member 8400, Desert Stars and other boards and committees leading initiatives in medical education and innovation, advancement of women and more.